Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting
09. Dezember 2024 07:00 ET
|
Orchestra BioMed Holdings, Inc.
NEW HOPE, Pa., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact...
Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference
26. November 2024 16:05 ET
|
Orchestra BioMed Holdings, Inc.
NEW HOPE, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to...
Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update
12. November 2024 16:12 ET
|
Orchestra BioMed Holdings, Inc.
NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact...
Orchestra BioMed to Participate in Jefferies London Healthcare Conference
07. November 2024 08:00 ET
|
Orchestra BioMed Holdings, Inc.
NEW HOPE, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to...
Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
12. August 2024 16:20 ET
|
Orchestra BioMed Holdings, Inc.
NEW HOPE, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact...
Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors
30. Juli 2024 08:00 ET
|
Orchestra BioMed Holdings, Inc.
John Mack brings over 30 years of diverse medical device and healthcare technology experience to the Orchestra BioMed Board of Directors Most recently, Mr. Mack served as Medtronic’s President of...
Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
04. Juni 2024 08:00 ET
|
Orchestra BioMed Holdings, Inc.
NEW HOPE, Pa., June 04, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to...
Orchestra BioMed to Participate in Jefferies Global Healthcare Conference
22. Mai 2024 08:43 ET
|
Orchestra BioMed Holdings, Inc.
NEW HOPE, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to...
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
13. Mai 2024 16:58 ET
|
Orchestra BioMed Holdings, Inc.
Company hosting in-person R&D day event, focused on atrioventricular interval modulation (“AVIM”) therapy, including the unmet need in hypertension, mechanism of action, clinical results and...
Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents
30. April 2024 08:30 ET
|
Orchestra BioMed Holdings, Inc.
Patent estate covering atrioventricular interval modulation (“AVIM”) therapy includes 37 issued U.S. patents and 73 patents outside the U.S. that collectively comprise over 1,800 claims related to the...